In a recent survey, cancer clinicians, researchers, and patient advocates overall ranked quality of life as the top value domain alongside survival, access to care, and toxicities, emphasizing the importance of including patient-reported outcomes (PROs) in clinical trials.
For more information: Quality of Life, Access Top Priorities in Cancer Care
This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service, or treatment.
